These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10370675)

  • 21. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C.
    Lusivika-Nzinga C; Fontaine H; Dorival C; Simony M; Pol S; Carrat F;
    J Viral Hepat; 2019 Dec; 26(12):1489-1492. PubMed ID: 31386252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.
    Jazag A; Puntsagdulam N; Chinburen J
    Korean J Intern Med; 2012 Jun; 27(2):121-7. PubMed ID: 22707881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis.
    Tsutsumi M; Ishizaki M; Takada A
    Alcohol Clin Exp Res; 1996 Jun; 20(4):758-62. PubMed ID: 8800396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
    Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
    Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.
    Matsumura H; Nirei K; Nakamura H; Higuchi T; Arakawa Y; Ogawa M; Tanaka N; Moriyama M
    World J Gastroenterol; 2013 Aug; 19(30):4887-96. PubMed ID: 23946593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma in cirrhotic liver in Trieste.
    Melato M; Valente M; Mucli E; Muuse MM; Taraglio S
    J Gastroenterol Hepatol; 1989; 4(6):521-7. PubMed ID: 2562353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
    Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
    Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival].
    Rodríguez-Vidigal FF; Baz MJ; Romero J; del Puerto M
    An Med Interna; 2005 Apr; 22(4):162-6. PubMed ID: 16004511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.